Kenneth Thompson

1.1k total citations
13 papers, 808 citations indexed

About

Kenneth Thompson is a scholar working on Neurology, Genetics and Organic Chemistry. According to data from OpenAlex, Kenneth Thompson has authored 13 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 5 papers in Genetics and 2 papers in Organic Chemistry. Recurrent topics in Kenneth Thompson's work include Amyotrophic Lateral Sclerosis Research (9 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Kenneth Thompson is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (9 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Kenneth Thompson collaborates with scholars based in United States and Switzerland. Kenneth Thompson's co-authors include Fernando G. Vieira, Joshua D. Kidd, Alan Gill, John Lincecum, Steven Perrin, Alan Bostrom, Janice E. Kranz, Sean Scott, Jeff Cole and Nancy Kelly and has published in prestigious journals such as Nature Genetics, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Kenneth Thompson

12 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth Thompson United States	10	498	259	249	114	106	13	808
Ruben J. Cauchi Malta	18	231 0.5×	535 2.1×	318 1.3×	104 0.9×	56 0.5×	37	898
Yu Jin Hwang South Korea	14	71 0.1×	346 1.3×	20 0.1×	185 1.6×	34 0.3×	29	689
Arun Pal Germany	16	477 1.0×	478 1.8×	112 0.4×	315 2.8×	158 1.5×	26	1.3k
Sonam Parakh Australia	14	398 0.8×	400 1.5×	143 0.6×	99 0.9×	64 0.6×	22	940
Simon Gutbier Germany	15	53 0.1×	350 1.4×	15 0.1×	136 1.2×	141 1.3×	21	732
Younghye Moon South Korea	15	128 0.3×	366 1.4×	11 0.0×	137 1.2×	75 0.7×	26	707
Constanze Riemer Germany	17	134 0.3×	822 3.2×	15 0.1×	93 0.8×	358 3.4×	23	1.1k
N. Izumiyama Japan	12	273 0.5×	233 0.9×	12 0.0×	141 1.2×	82 0.8×	21	755
Tiziana Alberio Italy	20	310 0.6×	414 1.6×	9 0.0×	236 2.1×	93 0.9×	47	973
CL Masters Australia	11	135 0.3×	910 3.5×	24 0.1×	143 1.3×	239 2.3×	18	1.4k

Countries citing papers authored by Kenneth Thompson

Since Specialization

Citations

This map shows the geographic impact of Kenneth Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Thompson more than expected).

Fields of papers citing papers by Kenneth Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Thompson. The network helps show where Kenneth Thompson may publish in the future.

Co-authorship network of co-authors of Kenneth Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Thompson. A scholar is included among the top collaborators of Kenneth Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Thompson. Kenneth Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Vieira, Fernando G., Joshua D. Kidd, Andrew Moreno, et al.. (2024). PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS. PLoS ONE. 19(2). e0292190–e0292190. 1 indexed citations

Hatzipetros, Theo, Joshua D. Kidd, Beth Levine, et al.. (2019). SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS. Scientific Reports. 9(1). 6724–6724. 50 indexed citations

Vieira, Fernando G., Theo Hatzipetros, Kenneth Thompson, et al.. (2017). CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits. IBRO Reports. 2. 47–53. 32 indexed citations

Hatzipetros, Theo, et al.. (2015). A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS. Journal of Visualized Experiments. 73 indexed citations

Vieira, Fernando G., Joshua D. Kidd, Kenneth Thompson, et al.. (2015). Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS. PLoS ONE. 10(8). e0135570–e0135570. 64 indexed citations

Vieira, Fernando G., Joshua D. Kidd, Beth Levine, et al.. (2014). Dexpramipexole Is Ineffective in Two Models of ALS Related Neurodegeneration. PLoS ONE. 9(12). e91608–e91608. 23 indexed citations

Lincecum, John, Fernando G. Vieira, Monica Z. Wang, et al.. (2010). From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nature Genetics. 42(5). 392–399. 96 indexed citations

Gill, Alan, Joshua D. Kidd, Fernando G. Vieira, Kenneth Thompson, & Steven Perrin. (2009). No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS. PLoS ONE. 4(8). e6489–e6489. 66 indexed citations

Scott, Sean, Janice E. Kranz, Jeff Cole, et al.. (2008). Design, power, and interpretation of studies in the standard murine model of ALS. Amyotrophic Lateral Sclerosis. 9(1). 4–15. 358 indexed citations

10.

Wislocki, Peter G., et al.. (2003). Residue Depletion Study and Withdrawal Period for Flunixin-N-methyl Glucamine in Bovine Milk Following Intravenous Administration. Journal of Agricultural and Food Chemistry. 51(16). 4701–4707. 11 indexed citations

11.

Feely, William F., et al.. (2002). Flunixin Residues in Milk after Intravenous Treatment of Dairy Cattle with¹⁴C-Flunixin. Journal of Agricultural and Food Chemistry. 50(25). 7308–7313. 32 indexed citations

12.

Thompson, Kenneth. (1984). Gang Stability Programs for Marketed Batches. Drug Development and Industrial Pharmacy. 10(8-9). 1449–1461. 1 indexed citations

13.

Thompson, Kenneth. (1975). The idea of longevity in early California.. PubMed. 51(7). 805–16. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact